Our top pick for
111 Inc is a pharmaceutical retailers business based in the US. 111 shares (YI) are listed on the NASDAQ and all prices are listed in US Dollars. 111 employs 2,189 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$5.57|
|52-week range||$5.01 - $30.99|
|50-day moving average||$6.27|
|200-day moving average||$8.34|
|Wall St. target price||$16.02|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.02|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-1.42%|
|1 month (2021-09-23)||-12.28%|
|3 months (2021-07-23)||-18.92%|
|6 months (2021-04-23)||-54.64%|
|1 year (2020-10-23)||-20.43%|
|2 years (2019-10-22)||16.04%|
|3 years (2018-10-23)||8.05|
|5 years (2016-10-19)||N/A|
|Revenue TTM||$10.6 billion|
|Gross profit TTM||$138.9 million|
|Return on assets TTM||-15.16%|
|Return on equity TTM||-73.09%|
|Market capitalisation||$468.2 million|
TTM: trailing 12 months
There are currently 879,996 111 shares held short by investors – that's known as 111's "short interest". This figure is 5.7% up from 832,268 last month.
There are a few different ways that this level of interest in shorting 111 shares can be evaluated.
111's "short interest ratio" (SIR) is the quantity of 111 shares currently shorted divided by the average quantity of 111 shares traded daily (recently around 319998.54545455). 111's SIR currently stands at 2.75. In other words for every 100,000 111 shares traded daily on the market, roughly 2750 shares are currently held short.
However 111's short interest can also be evaluated against the total number of 111 shares, or, against the total number of tradable 111 shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case 111's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 111 shares in existence, roughly 10 shares are currently held short) or 0.0329% of the tradable shares (for every 100,000 tradable 111 shares, roughly 33 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against 111.
Find out more about how you can short 111 stock.
We're not expecting 111 to pay a dividend over the next 12 months.
Over the last 12 months, 111's shares have ranged in value from as little as $5.01 up to $30.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 111's is 0.7801. This would suggest that 111's shares are less volatile than average (for this exchange).
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan.
Steps to owning and managing Valkyrie Bitcoin Strategy ETF units.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 21, 2021
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.